New imaging study tracks arthritis Drug's journey inside the body
NCT ID NCT07147959
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 16 times
Summary
This study uses special PET-CT scans to track a new drug called CIT-013 in people with rheumatoid arthritis. The drug aims to calm inflammation caused by immune cells. By seeing where the drug goes, researchers hope to learn how well it reaches affected tissues. About 12 adults aged 60-85 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NL-01
RECRUITINGNijmegen, Netherlands
Contact
Conditions
Explore the condition pages connected to this study.